Reagan-Udall Foundation For The Food And Drug Administration
- Assets
- $4.9m
- Revenue
- $5.4m
- Investments
- $0.0
- Employees
- 13
- Location
- Washington, DC
- Founding
- 03/2009
- Data as of
- 12/2021
- EIN
- 26-3727917
Organization Overview
Reagan-Udall Foundation For The Food And Drug Administration is located in Washington, DC. The organization was established in 2009. According to its NTEE Classification (F01) the organization is classified as: Alliances & Advocacy, under the broad grouping of Mental Health & Crisis Intervention and related organizations. As of 12/2021, Reagan-Udall Foundation For The Food And Drug Administration employed 13 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Reagan-Udall Foundation For The Food And Drug Administration is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Reagan-Udall Foundation For The Food And Drug Administration generated $5.4m in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 5.1% each year. All expenses for the organization totaled $5.3m during the year ending 12/2021. While expenses have increased by 2.3% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
ADVANCE THE MISSION OF THE FOOD AND DRUG ADMINISTRATION TO MODERNIZE PRODUCT DEVELOPMENT, ACCELERATE INNOVATION, AND ENHANCE PRODUCT SAFETY.
Describe the Organization's Program Activity:
Part 3 - Line 4a
ENCOURAGE INNOVATIVE RESEARCH & ANALYSIS - PROVIDE DATA ASSETS AND ANALYSIS TOOLS TO EXAMINE THE RISKS AND BENEFITS OF REGULATED PRODUCTS. EXAMPLES INCLUDE THE COVID-19 EVIDENCE ACCELERATOR, THE INNOVATION IN MEDICAL EVIDENCE AND DEVELOPMENT SURVEILLANCE (IMEDS) PROGRAM, AND THE ALGORITHM VALIDATION STUDIES PROGRAM.
IMPROVE PUBLIC UNDERSTANDING OF THE RISKS AND BENEFITS OF FDA-REGULATED PRODUCTS - IDENTIFY PRIORITY AREAS FOR CONSUMER, PATIENT AND PROVIDER EDUCATION IN AREAS OF EMERGING SCIENCE. EXAMPLES INCLUDE THE SKIN LIGHTENING CONSUMER SAFETY PROJECT, EXPANDED ACCESS NAVIGATOR, COVID-19 HUB, ANTIMICROBIAL USE DATA IN FOOD ANIMALS, AND THE NUTRITION COMMUNICATION NETWORK.
FACILITATE MULTI-STAKEHOLDER COLLABORATION - ENABLE EXPERT ANALYSIS AND CANDID DISCUSSION ON ISSUES RELEVANT TO THE FDA MISSION. EXAMPLES INCLUDE PATIENT LISTENING SESSIONS, SUBSTANCE USE DISORDERS, AND MULTIPLE EXPERT CONVENINGS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Susan C Winckler Rph JD Chief Executive Officer | Officer | 40 | $343,970 |
Amar Bhat PHD Chief Operating Officer | Officer | 40 | $197,562 |
Carla Rodriguez-Watson PHD Director Of Research | 40 | $190,000 | |
Lea Ann Mcnee MA Director Of Communications | 40 | $156,607 | |
David Woodbury MBA Director Of Operations | 40 | $156,000 | |
Alecia Clary PHD Associate Director Of Research | 40 | $132,784 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Harvard Pilgrim Health Care Imeds Data Partner | 12/30/19 | $121,250 |
Witt-kieffer Staff Recruting | 12/30/19 | $110,192 |
Alston & Bird Llp Legal Services | 12/30/19 | $121,707 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $415,800 |
| Related organizations | $0 |
| Government grants | $2,309,049 |
| All other contributions, gifts, grants, and similar amounts not included above | $38,071 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $2,762,920 |
| Total Program Service Revenue | $2,725,836 |
| Investment income | $1,358 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | -$55,347 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $5,435,911 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $601,955 |
| Compensation of current officers, directors, key employees. | $24,082 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $1,153,388 |
| Pension plan accruals and contributions | $58,859 |
| Other employee benefits | $86,963 |
| Payroll taxes | $119,475 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $110,580 |
| Fees for services: Accounting | $91,201 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $2,743,810 |
| Advertising and promotion | $15,324 |
| Office expenses | $18,965 |
| Information technology | $103,950 |
| Royalties | $0 |
| Occupancy | $118,188 |
| Travel | $757 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $832 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $43,812 |
| Insurance | $8,251 |
| All other expenses | $81 |
| Total functional expenses | $5,303,683 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $535,948 |
| Savings and temporary cash investments | $3,027,633 |
| Pledges and grants receivable | $498,455 |
| Accounts receivable, net | $726,936 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $55,376 |
| Net Land, buildings, and equipment | $52,050 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $14,032 |
| Total assets | $4,910,430 |
| Accounts payable and accrued expenses | $1,143,047 |
| Grants payable | $0 |
| Deferred revenue | $120,839 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $10,481 |
| Total liabilities | $1,274,367 |
| Net assets without donor restrictions | $3,578,725 |
| Net assets with donor restrictions | $57,338 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $4,910,430 |
Grants Awarded
Over the last fiscal year, Reagan-Udall Foundation For The Food And Drug Administration has awarded $342,999 in support to 3 organizations.
| Grant Recipient | Amount |
|---|---|
Somerville, MA PURPOSE: IMEDS Methods Research | $182,999 |
Chapel Hill, NC PURPOSE: IMEDS Methods Research | $100,000 |
Urbana, IL PURPOSE: IMEDS Methods Research | $60,000 |
Grants Recieved
Over the last fiscal year, we have identified 3 grants that Reagan-Udall Foundation For The Food And Drug Administration has recieved totaling $33,000.
| Awarding Organization | Amount |
|---|---|
Pharmaceutical Research And Manufacturers Of America Washington, DC PURPOSE: General Contribution | $15,000 |
Friends Of Cancer Research Washington, DC PURPOSE: ANNUAL CONTRIBUTION | $10,000 |
United States Pharmacopeial Convention Inc Rockville, MD PURPOSE: 2022 NATIONAL HEALTH COUNCIL DUES | $8,000 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Rock Creek Foundation For Mental Health Inc Silver Spring, MD | $5,711,128 | $9,918,719 |
Reagan-Udall Foundation For The Food And Drug Administration Washington, DC | $4,910,430 | $5,435,911 |
The We Card Program Inc Arlington, VA | $2,225,193 | $2,544,265 |
Faces And Voices Of Recovery Washington, DC | $1,367,908 | $2,538,070 |
Hanover Domestic Violence Task Force Inc Ashland, VA | $864,398 | $1,283,136 |
Putchie Foundation Bethesda, MD | $11,918,933 | $2,979,597 |
National Council On Alcoholism Maryland Chapter Inc Baltimore, MD | $421,163 | $474,525 |
Office Of Consumer Advocates Inc Hagerstown, MD | $100,153 | $590,083 |
Total Family Care Coalition Washington, DC | $129,692 | $499,721 |
Inseparable Action Inc Washington, DC | $474,646 | $795,540 |
Network Of Employers For Traffic Safety Vienna, VA | $641,031 | $467,160 |
Youth Mental Health Project Inc Silver Spring, MD | $256,363 | $280,049 |